Moisescu V, Mladin T, Popescu M, Ardevan A, Moll E, Kaba T
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1976 Oct-Dec;25(4):229-36.
The effectiveness of the intermittent treatment (2/7) with Rifampicin + Etambutol, administered over periods of 3 to 24 months, was tested in a log of 229 out-patients suffering from tuberculosis (bacilli carriers). Negativation of the cultures was obtained in 88.4% of the cases, most of the failures being recorded in the aged patients from rural areas, suffering from various other associated diseases and in those who did not cooperate. As these patients raise particular problems concerning the therapeutical attitude, the authors consider they should be admitted to hospital, at least during the critical periods of the disease.
对229例肺结核(杆菌携带者)门诊患者进行了为期3至24个月的利福平+乙胺丁醇间歇治疗(2/7)有效性测试。88.4%的病例培养结果转为阴性,大多数治疗失败病例出现在来自农村地区、患有各种其他伴发疾病且不配合治疗的老年患者中。由于这些患者在治疗态度方面存在特殊问题,作者认为他们至少在疾病的关键时期应住院治疗。